Esat Mahmut Ozsahin - ARCHIVE

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


252 publications

Sous presse | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | ...
Sous presse
 
ASO Visual Abstract: Low-Dose Radiation Yields Lower Rates of Pathologic Response in Esophageal Cancer Patients
Mantziari Styliani, Teixeira Farinha Hugo, Messier Marguerite, Winiker Michael, Allemann Pierre, Ozsahin Esat Mahmut, Demartines Nicolas, Piessen Guillaume, Schäfer Markus Annals of Surgical Oncology. Peer-reviewed.
[DOI][serval:BIB_2C5C5ECF7923]
2024
 
Low-Dose Radiation Yields Lower Rates of Pathologic Response in Esophageal Cancer Patients.
Mantziari S., Farinha H.T., Messier M., Winiker M., Allemann P., Ozsahin E.M., Demartines N., Piessen G., Schäfer M., 2024/04. Annals of surgical oncology, 31 (4) pp. 2499-2508. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6E98F3F586ED]
2023
 
Effect of Conventional and Ultrahigh Dose Rate FLASH Irradiations on Preclinical Tumor Models: A Systematic Analysis.
Böhlen T.T., Germond J.F., Petersson K., Ozsahin E.M., Herrera F.G., Bailat C., Bochud F., Bourhis J., Moeckli R., Adrian G., 2023/11/15. International journal of radiation oncology, biology, physics, 117 (4) pp. 1007-1017. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E35A0EBD9890]
3D-conformal very-high energy electron therapy as candidate modality for FLASH-RT: A treatment planning study for glioblastoma and lung cancer.
Böhlen T.T., Germond J.F., Traneus E., Vallet V., Desorgher L., Ozsahin E.M., Bochud F., Bourhis J., Moeckli R., 2023/09. Medical physics, 50 (9) pp. 5745-5756. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AE91AE049264]
 
In Reply to Horst et al.
Böhlen T.T., Germond J.F., Bochud F., Bailat C., Moeckli R., Bourhis J., Vozenin M.C., Ozsahin E.M., 2023/03/15. International journal of radiation oncology, biology, physics, 115 (4) pp. 1007-1009. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1EAB447A4311]
 
Lung stereotactic radiation therapy: Intercomparison of irradiation devices in terms of outcome and predictive factors.
Le Reun E., Casutt A., Durham A., Bouchaab H., Romano E., Lovis A., Krueger T., Von Garnier C., Özsahin E.M., Kinj R., 2023/02. Cancer radiotherapie, 27 (1) pp. 31-41. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0833BFD8386F]
2022
 
Normal Tissue Sparing by FLASH as a Function of Single-Fraction Dose: A Quantitative Analysis.
Böhlen T.T., Germond J.F., Bourhis J., Vozenin M.C., Ozsahin E.M., Bochud F., Bailat C., Moeckli R., 2022/12/01. International journal of radiation oncology, biology, physics, 114 (5) pp. 1032-1044. Peer-reviewed.
[DOI][Pmid][serval:BIB_03FA7A108554]
VoiceS: voice quality after transoral CO<sub>2</sub> laser surgery versus single vocal cord irradiation for unilateral stage 0 and I glottic larynx cancer-a randomized phase III trial.
Reinhardt P., Giger R., Seifert E., Shelan M., Riggenbach E., Terribilini D., Joosten A., Schanne D.H., Aebersold D.M., Manser P. et al., 2022/10/27. Trials, 23 (1) p. 906. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AA7128E6DDF6]
Improving Patients' Life Quality after Radiotherapy Treatment by Predicting Late Toxicities.
Lapierre A., Bourillon L., Larroque M., Gouveia T., Bourgier C., Ozsahin M., Pèlegrin A., Azria D., Brengues M., 2022/04/22. Cancers, 14 (9) p. 2097. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0FEF06F590D0]
 
Endobronchial Clip Device Insertion for Tracking Central Lesions.
Casutt A., Kinj R., Ozsahin E.M., von Garnier C., Gonzalez M., Lovis A., 2022/04/01. Journal of bronchology & interventional pulmonology, 29 (2) pp. e18-e20. Peer-reviewed.
[DOI][Pmid][serval:BIB_88984DEF5126]
Fiducial markers for stereotactic lung radiation therapy: review of the transthoracic, endovascular and endobronchial approaches.
Casutt A., Kinj R., Ozsahin E.M., von Garnier C., Lovis A., 2022/03/31. European respiratory review, 31 (163) p. 210149. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_784DA94BCCE2]
2021
 
Prognostic impact of extranodal extension in resected head and neck squamous cell carcinomas in the era of postoperative chemoradiation: A retrospective monocentric study.
Gau M., Fonseca A., Ozsahin M., Fayette J., Poupart M., Roux P.E., Schütz F., Zrounba P., Grégoire V., 2021/12. Oral oncology, 123 p. 105605. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4446FA1BC358]
Prise en charge des sarcomes des tissus mous abdominaux [Management of abdominal soft tissue sarcomas]
Djafarrian R., Zingg T., Digklia A., Becce F., Özsahin E.M., La Rosa S., Demartines N., Matter M., 2021/06/16. Revue medicale suisse, 17 (743) pp. 1172-1176. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B1CF53F8316E]
 
Endobronchial coil spring fiducial markers for CyberKnife® stereotactic body radiation therapy.
Casutt A., Noirez L., Bernasconi M., Koutsokera A., Beigelman-Aubry C., Kinj R., Ozsahin E.M., Durham A.D., von Garnier C., Lovis A., 2021/05. Respirology, 26 (5) pp. 469-476. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C98C6D8E75E9]
2020
 
Vertebral compression fracture during stereotactic body radiotherapy for spinal metastasis: A rare case of tracking failure.
Godin S., Durham A.D., Schiappacasse L., Ozsahin E.M., Vilotte F., 2020/12. Cancer radiotherapie, 24 (8) pp. 866-869. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_13E546BAAD65]
 
PO-0956: Neuroendocrine Tumors of the Breast: an international series of the Rare Cancer Network
Grellier-Adedjouma N., Paix A., Franco P., Kirova Y.M., De Bari B., Pasquier D., Meijer H., Oksüz D.C., Peignaux-Casasnovas K., Huguet F. et al., 2020/11., ESTRO 2020 - Online Congress, 28 November to 1 December 2020 pp. S510-S511 dans Radiotherapy and Oncology. Peer-reviewed.
[DOI][serval:BIB_131F757D31E7]
Exploration of clinical preferences in treatment planning of radiotherapy for prostate cancer using Pareto fronts and clinical grading analysis.
Kyroudi A., Petersson K., Ozsahin E., Bourhis J., Bochud F., Moeckli R., 2020/04. Physics and imaging in radiation oncology, 14 pp. 82-86. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D27CE2B93EFE]
 
Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer.
Giralt J., Tao Y., Kortmann R.D., Zasadny X., Contreras-Martinez J., Ceruse P., Arias de la Vega F., Lalla R.V., Ozsahin E.M., Pajkos G. et al., 2020/02/01. International journal of radiation oncology, biology, physics, 106 (2) pp. 320-328. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_384C28D80AFF]
2019
 
Outils pour la prédiction de la réponse tumorale et des tissus sains en oncologie radiothérapie [Predictive assays for responses of tumors and normal tissues in radiation oncology]
Riou O., Bourgier C., Brengues M., Bonnefoi N., Michaud H.A., Castan F., Gourgou S., Draghici R., Farcy-Jacquet M.P., Bons F. et al., 2019/10. Cancer radiotherapie, 23 (6-7) pp. 666-673. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C28C3E2DC61D]
 
Personnalisation de la dose, du volume et du fractionnement de la radiothérapie du sein [Individual modification of the dose, volume and fractionation of breast radiotherapy]
Bourgier C., Lemanski C., Draghici R., Castan F., Fenoglietto P., Bons F., Farcy-Jacquet M.P., Brengues M., Gourgou S., Ozsahin M. et al., 2019/10. Cancer radiotherapie, 23 (6-7) pp. 778-783. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0F0E75A4FBF5]
Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer—A Multicenter Study
Elicin Olgun, Ermiş Ekin, Oehler Christoph, Aebersold Daniel M., Caparrotti Francesca, Zimmermann Frank, Studer Gabriela, Henke Guido, Adam Lukas, Anschuetz Lukas et al., 2019/09/20. Frontiers in Oncology, 9.
[URN][DOI][WoS][serval:BIB_C091A29EFF41]
 
Current landscape of palliative radiotherapy for non-small-cell lung cancer.
Jumeau R., Vilotte F., Durham A.D., Ozsahin E.M., 2019/09. Translational lung cancer research, 8 (Suppl 2) pp. S192-S201. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F60DE3B57B77]
 
Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial.
Riesterer O., Ciernik I.F., Stahel R.A., Xyrafas A., Aebersold D.M., Plasswilm L., Mahmut Ozsahin E., Zwahlen D.R., Nackaerts K., Zimmermann F. et al., 2019/09. Radiotherapy and oncology, 138 pp. 121-125. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_22367B6D2F75]
Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity.
Lacombe J., Brengues M., Mangé A., Bourgier C., Gourgou S., Pèlegrin A., Ozsahin M., Solassol J., Azria D., 2019/08/09. Radiation oncology, 14 (1) p. 142. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5717C8853286]
Emerging patient-specific treatment modalities in head and neck cancer - a systematic review.
Elicin O., Cihoric N., Vlaskou Badra E., Ozsahin M., 2019/04. Expert opinion on investigational drugs, 28 (4) pp. 365-376. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2709C035C3A9]
 
Lung Adenocarcinoma Metastasis to the Prostate: A Case Report.
Gilmour N., Mampuya W.A., Jumeau R., Dattner N., Ozsahin M., 2019/03. Practical radiation oncology, 9 (2) pp. 77-80. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CF3E9AD2D040]
 
Primary extranodal lymphoma of the glands. Literature review and options for best practice in 2019.
Belkacemi Y., Sio T.T., Colson-Durand L., Onal C., Villà S., Anacak Y., Krengli M., Thariat J., Ugurluer G., Miller R.C. et al., 2019/03. Critical reviews in oncology/hematology, 135 pp. 8-19. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DB917F9DD87C]
 
Chimioradiothérapie des cancers de l’œsophage : revue critique de la littérature [Chemoradiation for oesophageal cancer: A critical review of the literature]
Blais E., Vendrely V., Sargos P., Créhange G., Huguet F., Maingon P., Simon J.M., Bourdais R., Ozsahin M., Bourhis J. et al., 2019/02. Cancer radiotherapie, 23 (1) pp. 62-72. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3CB618748C66]
 
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP).
Peters S., Dafni U., Boyer M., De Ruysscher D., Faivre-Finn C., Felip E., Garrido P., Girard N., Guckenberger M., Haanen J. et al., 2019/02/01. Annals of oncology, 30 (2) pp. 161-165. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_996A49F24542]
 
Practical clinical guidelines for contouring the trigeminal nerve (V) and its branches in head and neck cancers.
Biau J., Dunet V., Lapeyre M., Simon C., Ozsahin M., Grégoire V., Bourhis J., 2019/02. Radiotherapy and oncology, 131 pp. 192-201. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F44E590836BE]
 
The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients.
Vozenin M.C., De Fornel P., Petersson K., Favaudon V., Jaccard M., Germond J.F., Petit B., Burki M., Ferrand G., Patin D. et al., 2019/01/01. Clinical cancer research, 25 (1) pp. 35-42. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CD8C3C9FC9A2]
2018
 
Analysis of the treatment plan evaluation process in radiotherapy through eye tracking.
Kyroudi A., Petersson K., Ozsahin M., Bourhis J., Bochud F., Moeckli R., 2018/12. Zeitschrift fur medizinische Physik, 28 (4) pp. 318-324. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_841A6F502AE7]
 
Total-body irradiation using linac-based volumetric modulated arc therapy: Its clinical accuracy, feasibility and reliability.
Tas B., Durmus I.F., Okumus A., Uzel O.E., Gokce M., Goksoy H.S., Ozsahin E.M., 2018/12. Radiotherapy and oncology, 129 (3) pp. 527-533. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_17DAF1080FC2]
 
Adaptive radiotherapy for head and neck cancer.
Castelli J., Simon A., Lafond C., Perichon N., Rigaud B., Chajon E., De Bari B., Ozsahin M., Bourhis J., de Crevoisier R., 2018/10. Acta oncologica, 57 (10) pp. 1284-1292. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4D054507CBEA]
 
Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy.
Klausner G., Blais E., Jumeau R., Biau J., de Meric de Bellefon M., Ozsahin M., Zilli T., Miralbell R., Thariat J., Troussier I., 2018/08/20. Medical oncology, 35 (10) p. 134. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A69931C0EE76]
 
Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation.
Jumeau R., Ozsahin M., Schwitter J., Vallet V., Duclos F., Zeverino M., Moeckli R., Pruvot E., Bourhis J., 2018/08. Radiotherapy and oncology, 128 (2) pp. 189-191. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_157E3B9BB62F]
 
In Regard to Pereira et al.
Azria D., Gourgou S., Brengues M., Bourgier C., Ozsahin M., 2018/06/01. International journal of radiation oncology, biology, physics, 101 (2) pp. 490-491. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_275888713DFE]
(F-18)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy.
Scher N., Castelli J., Depeursinge A., Bourhis J., Prior J.O., Herrera F.G., Ozsahin M., 2018/05. Cancer radiotherapie, 22 (3) pp. 229-235. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8D0209EBDD82]
 
Modern intensity-modulated radiotherapy with image guidance allows low toxicity rates and good local control in chemoradiotherapy for anal cancer patients.
De Bari B., Lestrade L., Franzetti-Pellanda A., Jumeau R., Biggiogero M., Kountouri M., Matzinger O., Miralbell R., Bourhis J., Ozsahin M. et al., 2018/04. Journal of cancer research and clinical oncology, 144 (4) pp. 781-789. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_49A2277749ED]
 
Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.
Atalar B., Ozsahin M., Call J., Napieralska A., Kamer S., Villa S., Erpolat P., Negretti L., Lassen-Ramshad Y., Onal C. et al., 2018/04. Radiotherapy and oncology, 127 (1) pp. 96-102. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_867DFDC10223]
Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial.
Bourgier C., Castan F., Riou O., Nguyen T.D., Peignaux K., Lemanski C., Lagrange J.L., Kirova Y., Lartigau E., Belkacemi Y. et al., 2018/03/20. Oncotarget, 9 (21) pp. 15757-15765. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_289EF15FCDC6]
Comparison of 3DCRT and VMAT treatment in neoadjuvant oesophageal cancer.
Santa Cruz O (eds.), 2018/03., 92 Suppl 2.
[URN][DOI][Pmid][serval:BIB_46818D1BE984]
Hepatobiliary scintigraphy allows the evaluation of short-term functional toxicity of liver stereotactic body radiotherapy: Results of a pilot study.
De Bari B., Breuneval T., Zeverino M., Godin S., Deantonio L., Geldhof C., Bourhis J., Schaefer N., Moeckli R., Prior J. et al., 2018. PloS one, 13 (10) pp. e0204013. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_79CF07459545]
 
Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.
Santa Cruz O., Tsoutsou P., Castella C., Khanfir K., Anchisi S., Bouayed S., Matzinger O., Ozsahin M., 2018. Oncology, 95 (2) pp. 61-68. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D70AE74A893E]
2017
Outcome of proximal esophageal cancer after definitive combined chemo-radiation: a Swiss multicenter retrospective study.
Herrmann E., Mertineit N., De Bari B., Hoeng L., Caparotti F., Leiser D., Jumeau R., Cihoric N., Jensen A.D., Aebersold D.M. et al., 2017/06/14. Radiation oncology, 12 (1) p. 97. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E4A4DDC47242]
 
18-FDG PET-CT parameters to predict survival and recurrence in cervical cancer patients treated with chemo-radiotherapy
Scher Nathaniel, Castelli Joel, Depeursinge Adrien, Breuneval T., Bourhis J ., Prior John O., Ozsahin Esat, Herrera Fernanda, 2017/05., European Society for Radiotherapy and Oncology dans European Society for Radiotherapy and Oncology.
[serval:BIB_BDB032481E57]
 
The latest prospects of investigational drugs for head and neck cancer.
Elicin O., Ozsahin M., 2017/03. Expert opinion on investigational drugs, 26 (3) pp. 265-268. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_38B2CC14D9E6]
 
Can Segmentectomy Still Be Proposed As an Alternative to Lobectomy in 2016?
De Bari B., Durham A., Bourhis J., Ozsahin M., 2017/02/10. Journal of clinical oncology, 35 (5) pp. 573-574. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CF41C886AEDA]
 
T lymphocytes to predict radiation-induced late effects in normal tissues.
Brengues M., Lapierre A., Bourgier C., Pèlegrin A., Özsahin M., Azria D., 2017/02. Expert review of molecular diagnostics, 17 (2) pp. 119-127. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9F1C94CD71E9]
 
Chest-MRI under pulsatile flow ventilation: A new promising technique.
Beigelman-Aubry C., Peguret N., Stuber M., Delacoste J., Belmondo B., Lovis A., Simons J., Long O., Grant K., Berchier G. et al., 2017. PloS one, 12 (6) pp. e0178807. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_61A86B64EF6E]
 
Dose-dependent effects of adiponectin on ADAMTS-9 gene expression in human chondrocytes.
Yaykasli K.O., Hatipoglu O.F., Yaykasli E., Kaya E., Ozsahin M., Uslu M., 2017. Bratislavske lekarske listy, 118 (7) pp. 386-390. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6AEC83C53415]
2016
Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy.
Castelli J., De Bari B., Depeursinge A., Simon A., Devillers A., Roman Jimenez G., Prior J., Ozsahin M., de Crevoisier R., Bourhis J., 2016/12. Critical reviews in oncology/hematology, 108 pp. 40-51. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C4724EBB7453]
 
Role of functional imaging in treatment plan optimization of stereotactic body radiation therapy for liver cancer.
De Bari B., Jumeau R., Deantonio L., Adib S., Godin S., Zeverino M., Moeckli R., Bourhis J., Prior J.O., Ozsahin M., 2016/10/13. Tumori, 102 (5) pp. e21-e24. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1A1BF451D4B5]
 
Aromatase inhibitors decrease radiation-induced lung fibrosis: Results of an experimental study.
Altinok A.Y., Yildirim S., Altug T., Sut N., Ober A., Ozsahin E.M., Azria D., Bese N.S., 2016/08. Breast (Edinburgh, Scotland), 28 pp. 174-177. Peer-reviewed.
[DOI][Pmid][serval:BIB_F28B3D254082]
 
Discrepancies between selected Pareto optimal plans and final deliverable plans in radiotherapy multi-criteria optimization.
Kyroudi A., Petersson K., Ghandour S., Pachoud M., Matzinger O., Ozsahin M., Bourhis J., Bochud F., Moeckli R., 2016/08. Radiotherapy and oncology, 120 (2) pp. 346-348. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CE39A063851D]
 
Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation therapy.
De Bari B., Porta L., Mazzola R., Alongi F., Wagner A.D., Schäfer M., Bourhis J., Ozsahin M., 2016/07. Critical reviews in oncology/hematology, 103 pp. 49-61. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EE057E94F72E]
Traitement curatif du cancer de l'oesophage: consensus multidisciplinaire multicentrique [Curative treatment for esophageal cancer: results of a multidisciplinary consensus]
Allemann P., Mantziari S., Wagner D., Digklia A., Ozsahin E., De Bari B., Dorta G., Godat S., Montserrat F., Sempoux C. et al., 2016/06/15. Revue medicale suisse, 12 (523) pp. 1165-1169. Peer-reviewed.
[URN][Pmid][serval:BIB_58E6531A0AFA]
 
Current Role of Dacomitinib in Head and Neck Cancer.
Elicin O., Ozsahin M., 2016/06. Expert opinion on investigational drugs, 25 (6) pp. 735-742. Peer-reviewed.
[DOI][Pmid][serval:BIB_252EC8A01882]
 
Efficacy and safety of helical tomotherapy with daily image guidance in anal canal cancer patients.
De Bari B., Jumeau R., Bouchaab H., Vallet V., Matzinger O., Troussier I., Mirimanoff R.O., Wagner A.D., Hanhloser D., Bourhis J. et al., 2016/06. Acta oncologica (Stockholm, Sweden), 55 (6) pp. 767-773. Peer-reviewed.
[DOI][Pmid][serval:BIB_BBF294B0BDC2]
 
Should we include SPECT lung perfusion in radiotherapy treatment plans of thoracic targets? Evidences from the literature.
De Bari B., Deantonio L., Bourhis J., Prior J.O., Ozsahin M., 2016/06. Critical reviews in oncology/hematology, 102 pp. 111-117. Peer-reviewed.
[DOI][Pmid][serval:BIB_58638AE058BE]
Optimization of re-irradiation using deformable registration: a case study
Jumeau Raphaël, Péguret Nicolas, Zulliger Cédric, Moeckli Raphaël, Bourhis Jean, Ozsahin Esat-Mahmut, 2016/05. BJR|case reports, 2 (2) p. 20150412. Peer-reviewed.
[URN][DOI][serval:BIB_35DB427264AD]
[(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
Herrera F.G., Breuneval T., Prior J.O., Bourhis J., Ozsahin M., 2016/03/16. Radiation oncology, 11 p. 43. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7EB4C9B21B02]
Reduction of Respiratory Motion During PET/CT by Pulsatile-Flow Ventilation: A First Clinical Evaluation.
Prior J.O., Péguret N., Pomoni A., Pappon M., Zeverino M., Belmondo B., Lovis A., Ozsahin M., Vienne M., Bourhis J., 2016/03. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 57 (3) pp. 416-419. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DA38095A6DCE]
 
Apnea-like suppression of respiratory motion: First evaluation in radiotherapy.
Péguret N., Ozsahin M., Zeverino M., Belmondo B., Durham A.D., Lovis A., Simons J., Long O., Duclos F., Prior J. et al., 2016. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology, 118 (2) pp. 220-226. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_721A2FE5C894]
 
Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial?.
Bourgier C., Kerns S., Gourgou S., Lemanski C., Gutowski M., Fenoglietto P., Romieu G., Crompton N., Lacombe J., Pèlegrin A. et al., 2016. Annals of Oncology, 27 (3) pp. 474-480. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7D4F948355EB]
Primary Hepatic Lymphoma: A Retrospective, Multicenter Rare Cancer Network Study.
Ugurluer G., Miller R.C., Li Y., Thariat J., Ghadjar P., Schick U., Ozsahin M., 2016. Rare Tumors, 8 (3) p. 6502. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1CF652058495]
2015
 
Treatment deintensification and symptom burden in patients with human papillomavirus-associated head and neck cancer.
Ozsahin M., Bourhis J., 2015/11. Cancer, 121 (7) pp. 1147-1148. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8E492303C543]
 
Late side-effects after curative intent radiotherapy: Identification of hypersensitive patients for personalized strategy.
Bourgier C., Lacombe J., Solassol J., Mange A., Pèlegrin A., Ozsahin M., Azria D., 2015. Critical Reviews in Oncology/hematology, 93 (3) pp. 312-319. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D613E45778BB]
 
Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.
Giralt J., Trigo J., Nuyts S., Ozsahin M., Skladowski K., Hatoum G., Daisne J.F., Yunes Ancona A.C., Cmelak A., Mesía R. et al., 2015. Lancet. Oncology, 16 (2) pp. 221-232. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7F0E8D497F06]
Patterns of practice of regional nodal irradiation in breast cancer: results of the European Organization for Research and Treatment of Cancer (EORTC) NOdal Radiotherapy (NORA) survey.
Belkacemi Y., Kaidar-Person O., Poortmans P., Ozsahin M., Valli M.C., Russell N., Kunkler I., Hermans J., Kuten A., van Tienhoven G. et al., 2015. Annals of Oncology, 26 (3) pp. 529-535. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_38D91B4228D2]
Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial.
Azria D., Riou O., Castan F., Nguyen T.D., Peignaux K., Lemanski C., Lagrange J.L., Kirova Y., Lartigau E., Belkacemi Y. et al., 2015. Ebiomedicine, 2 (12) pp. 1965-1973. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FAEEE27F5350]
 
Small Cell Carcinoma of the Urinary Bladder: A Retrospective, Multicenter Rare Cancer Network Study of 107 Patients.
Pasquier D., Barney B., Sundar S., Poortmans P., Villa S., Nasrallah H., Boujelbene N., Ghadjar P., Lassen-Ramshad Y., Senkus E. et al., 2015. International Journal of Radiation Oncology, Biology, Physics, 92 (4) pp. 904-910. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B0FF16B354ED]
2014
 
La radiothérapie postopératoire a-t-etlle une place dans le cancer pulmonaire ? [Postoperative radiation therapy in lung carcinom]
Bouchaab H., Peters S., Ozsahin M., Peguret N., Gonzales M., Lovis A., 2014/05/21. Revue medicale suisse, 10 (431) pp. 1110-1113. Peer-reviewed.
[Pmid][serval:BIB_58D9608BE954]
 
[(18)F]FDG-PET Standard Uptake Value as a Metabolic Predictor of Bone Marrow Response to Radiation: Impact on Acute and Late Hematological Toxicity in Cervical Cancer Patients Treated With Chemoradiation Therapy.
Elicin O., Callaway S., Prior J.O., Bourhis J., Ozsahin M., Herrera F.G., 2014. International Journal of Radiation Oncology, Biology, Physics, 90 (5) pp. 1099-1107. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9B5C992E8C1E]
 
Cancer du sein: radiothérapie et signalisation oestrogénique [Breast cancer: radiotherapy and estrogen signaling].
Bourgier C., Lemanski C., Romieu G., Ozsahin M., Azria D., 2014. Bulletin du Cancer, 101 (7-8) pp. 714-717. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E805CFB28C7C]
 
Early investigational drugs that target epidermal growth factor receptors for the treatment of head and neck cancer.
Ugurluer G., Ozsahin M., 2014. Expert Opinion on Investigational Drugs, 23 (12) pp. 1637-1654. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5FCAF852B7A1]
History of the rare cancer network and past research.
Mirimanoff R.O., Ozsahin M., Thariat J., Ozyar E., Schick U., Pehlivan B., Krengli M., Pellanda A.F., Vees H., Cai L. et al., 2014. Rare Tumors, 6 (3) p. 5462. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D2A320CA5C0D]
 
Le réseau international des cancers rares [RCN, Rare Cancer Network].
Mirimanoff R.O., Thariat J., Belkacemi Y., Villa S., Ozyar E., Krengli M., Miller R.C., Ozsahin M., le Rare Cancer Network Oncologie radiothérapie, 2014. Bulletin Du Cancer, 101 (9) pp. 778-779.
[DOI][WoS][Pmid][serval:BIB_8FB1E7CE4723]
Long-term Outcome and Late Side Effects in Endometrial Cancer Patients Treated with Surgery and Postoperative Radiation Therapy.
Herrera F.G., Cruz O.S., Achtari C., Bourhis J., Ozsahin M., 2014. Annals of Surgical Oncology, 21 (7) pp. 2390-2397.
[URN][DOI][WoS][Pmid][serval:BIB_9652529431A0]
 
Radiation-induced sequelae measured by lymphocyte apoptosis: in regard to Foro et al.
Ozsahin M., Azria D., 2014. International Journal of Radiation Oncology, Biology, Physics, 90 (2) p. 470. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_481B2B7D4044]
The rare cancer network: ongoing studies and future strategy.
Ozsahin M., Mirimanoff R.O., Thariat J., Sun X.S., Atalar B., Lassen-Ramshad Y., Ugurluer G., Krishnan S., Hallemeier C., Houtte P.V. et al., 2014. Rare Tumors, 6 (3) p. 5465. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B27A9B65E103]
2013
 
Nomograms predicting locoregional recurrence in the subtype era of breast cancer.
Tsoutsou P.G., Jeanneret Sozzi W., Matzinger O., Ozsahin M., 2013/02/10. Journal of clinical oncology, 31 (5) pp. 647-648. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EEB77FCDD35C]
 
Adenosquamous carcinoma of the head and neck: report of 20 cases and review of the literature.
Schick U., Pusztaszeri M., Betz M., Ghadjar P., Demiroz C., Kaanders J.H., Ozsahin M., 2013. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 116 (3) pp. 313-320. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8C325269EDBB]
 
Radiosensibilité individuelle : les tests vont changer nos pratiques [Intrinsic radiosensitivity: predictive assays that will change the daily practice].
Lacombe J., Riou O., Solassol J., Mangé A., Bourgier C., Fenoglietto P., Pèlegrin A., Ozsahin M., Azria D., 2013. Cancer Radiothérapie, 17 (5-6) pp. 337-343.
[DOI][WoS][Pmid][serval:BIB_31527A9EF138]
 
Radiotherapy options after breast-conserving surgery: how can selection of patients be refined?
Tsoutsou P.G., Jeanneret Sozzi W., Ozsahin M., Delaloye J.F., Bourhis J., 2013. Journal of Clinical Oncology, 31 (36) pp. 4570-4571. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C8D10DF8C575]
Retrospective feasibility study of simultaneous integrated boost in cervical cancer using Tomotherapy: the impact of organ motion and tumor regression.
Herrera F.G., Callaway S., Delikgoz-Soykut E., Coskun M., Porta L., Meuwly J.Y., Soares-Rodrigues J., Heym L., Moeckli R., Ozsahin M., 2013. Radiation Oncology, 8 (5) pp. 1-10. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A4AEBB0F5438]
 
The Effect of Amifostine on Acute and Late Radiation Side Effects in Head and Neck Cancer Patients
Demiroz C., Ozkan L., Cebelli G., Karadag O., Ozsahin E.M., 2013. Turkiye Klinikleri Tip Bilimleri Dergisi, 32 (5) pp. 1207-1216.
[DOI][WoS][serval:BIB_7DBE15E9107D]
The use of PET/CT in radiotherapy planning: contribution of deformable registration.
Delikgoz Soykut E., Ozsahin E.M., Yukselen Guney Y., Aytac Arslan S., Derinalp Or O., Altundag M.B., Ugurluer G., Tsoutsou P.G., 2013. Frontiers In Oncology, 3 p. 33. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C6E2180DCFA9]
2012
 
Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94).
Ghadjar P., Simcock M., Studer G., Allal A.S., Ozsahin M., Bernier J., Töpfer M., Zimmermann F., Betz M., Glanzmann C. et al., 2012. International Journal of Radiation Oncology, Biology, Physics, 82 (2) pp. 524-531.
[DOI][WoS][Pmid][serval:BIB_281A4BFB6542]
 
Definitive organ-sparing treatment of anal canal cancer: can we afford to question it?
Ozsahin M., Santa Cruz O., Bouchaab H., Matzinger O., Tsoutsou P.G., 2012. Journal of Clinical Oncology, 30 (6) pp. 673-675.
[DOI][WoS][Pmid][serval:BIB_0DC9B2091652]
 
Early-Stage Primary Bone Lymphoma: A Retrospective, Multicenter Rare Cancer Network (RCN) Study.
Cai L., Stauder M.C., Zhang Y.J., Poortmans P., Li Y.X., Constantinou N., Thariat J., Kadish S.P., Nguyen T.D., Kirova Y.M. et al., 2012. International Journal of Radiation Oncology, Biology, Physics, 83 (1) pp. 284-291.
[DOI][WoS][Pmid][serval:BIB_D5857DBFA0C5]
 
Impact of Prophylactic Cranial Irradiation Timing on Brain Relapse Rates in Patients With Stage IIIB Non-Small-Cell Lung Carcinoma Treated With Two Different Chemoradiotherapy Regimens.
Topkan E., Parlak C., Kotek A., Yuksel O., Cengiz M., Ozsahin M., Pehlivan B., 2012. International Journal of Radiation Oncology, Biology, Physics, 83 (4) pp. 1264-1271.
[DOI][WoS][Pmid][serval:BIB_408E90866DE9]
 
Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy?
Zilli T., Schick U., Ozsahin M., Gervaz P., Roth A.D., Allal A.S., 2012. Radiotherapy and Oncology, 102 (1) pp. 62-67.
[DOI][WoS][Pmid][serval:BIB_604964E43F26]
 
Primary mucosa-associated lymphoid tissue lymphoma of the salivary glands: a multicenter Rare Cancer Network study.
Anacak Y., Miller R.C., Constantinou N., Mamusa A.M., Epelbaum R., Li Y., Calduch A.L., Kowalczyk A., Weber D.C., Kadish S.P. et al., 2012. International Journal of Radiation Oncology, Biology, Physics, 82 (1) pp. 315-320.
[DOI][WoS][Pmid][serval:BIB_87086484BE22]
 
Response to "Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy." (Int J Radiat Oncol Biol Phys 2011;80:398-402).
Tsoutsou P.G., Jeanneret Sozzi W., Ozsahin M., 2012. International Journal of Radiation Oncology, Biology, Physics, 82 (2) p. 519.
[DOI][WoS][Pmid][serval:BIB_127225E3B7E4]
The Rare Cancer Network: achievements from 1993 to 2012.
Patel A., Ozsahin M., Mirimanoff R.O., Bhatia S., Chang K., Miller R.C., 2012. Rare Tumors, 4 (3) pp. e35.
[URN][DOI][Pmid][serval:BIB_29A86767B2F1]
2011
 
A Cell Permeable Rasgap-derived Peptide Sensitizes Cancer Cells To Radiotherapy
Viertl D., Annibaldi A., Oezsahin M., Mirimanoff R., Widmann C., Matzinger O., 2011. pp. S738 dans ASTRO 2011, 53rd Annual Meeting of the American Society for Radiation Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.
[DOI][WoS][serval:BIB_A7A569657C12]
 
Carotid Dose Spring in Definitive Irradiation of T1N0 Squamous Cell Laryngeal Carcinoma Using Helical Tomotherapy
Cosinschi A., Khanfir K., Joosten A., Boujelbene N., Herrera F., Pachoud M., Matzinger O., Ozsahin M., 2011. pp. S518-S519 dans ASTRO 2011, 53rd Annual Meeting of the American Society for Radiation Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.
[DOI][WoS][serval:BIB_552A44D45017]
 
Carotid sparing in definitive irradiation of T1N0 squamous cell larnyx cancer using helical tomotherapy
Cosinschi A., Khanfir K., Joosten A., Bouchaab H., Herrara E., Pachoud M., Matzinger O., Mirimanoff R., Ozsahin M., 2011. p. 685 dans ICT 2011, International Conference on Tomotherapy, Strahlentherapie und Onkologie. Peer-reviewed.
[WoS][serval:BIB_A3BC9C15F329]
 
Carotid sparing in t1-t2 no glottic cancer using helical tomotherapy
Cosinschi A., Khanfir K., Boujelbene N., Herrera F., Pachoud M., Matzinger O., Ozsahin M., 2011. p. 536 dans 15th Annual Meeting of the Scientific Association of Swiss Radiation Oncology, Strahlentherapie und Onkologie. Peer-reviewed.
[WoS][serval:BIB_CD670E5ED273]
 
Combined radiohormonotherapy in node positive lymph node prostate cancer
Herrmann E., Boujelbene N., Ozsahin M., Khanfir K., Mirimanoff R.O., Jichlinski P., Gygi C., Zouhair A., 2011. p. 537 dans 15th Annual Meeting of the Scientific Association of Swiss Radiation Oncology, Strahlentherapie und Onkologie. Peer-reviewed.
[WoS][serval:BIB_57BCC6996D76]
 
Concurrent or Sequential Adjuvant Letrozole and Radiotherapy after Conservative Surgery for Early-stage Breast Cancer: Long-term Results of the Cohort Phase 2 Randomized Trial
Azria D., Lemanski C., Romieu G., Gutowski M., Gourgou S., Moscardo C.L., Fenoglietto P., Ozsahin M., 2011. pp. S34-S35 dans ASTRO 2011, 53rd Annual Meeting of the American Society for Radiation Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.
[DOI][WoS][serval:BIB_F449702771D6]
 
Early stage primary bone lymphoma - a retrospective, multicenter rare cancer network (rcn) study
Cai L., Stauder M.C., Zhang Y.J., Poortmans P., Li Y.X., Constantinou N., Thariat J., Kadish S., Nguyen T.D., Kirova Y.M. et al., 2011. p. 538 dans 15th Annual Meeting of the Scientific Association of Swiss Radiation Oncology, Strahlentherapie und Onkologie. Peer-reviewed.
[WoS][serval:BIB_A6CAD49AEB93]
 
Estimation of Radiation Dose and Cancer Risk Following Diagnostic and Therapeutic Radiation Exposure in Stage I Seminoma Patients
Herrera F., Heym L., Le Coultre R., Joosten A., Verdun F., Moeckli R., Ozsahin M., Berthold D., 2011. dans SASRO 2011, Scientific Association of Swiss Radiation Oncology.
[serval:BIB_D04377227508]
 
Helical tomotherapy in the treatment of anal canal cancer: 3-year clinical experience
Bouchaab H., Matzinger O., Ugurluer G., Pachoud M., Vallet V., Mirimanoff R., Ozsahin M., 2011. p. 683 dans ICT 2011, International Conference on Tomotherapy, Strahlentherapie und onkologie. Peer-reviewed.
[WoS][serval:BIB_D15EB233648F]
 
Hippocampal sparing whole brain radiotherapy and simultaneously integrated boost with helical tomotherapy in patients with brain metastases
Coskun M., Negretti L., Herrmann E., Breunewal T., Mirimanoff R., Ozsahin M., 2011. p. 698 dans ICT 2011, International Conference on Tomotherapy, Strahlentherapie und Onkologie. Peer-reviewed.
[WoS][serval:BIB_3E1CFB709A94]
 
Intérêt de la tomographie par émission de positons couplée à la scanographie (TEP/TDM) dans les cancers urologiques [Value of positron emission tomography and computer tomography (PET/CT) for urologic malignancies].
Boujelbene N., Prior J.O., Boubaker A., Azria D., Schaffer M., Gez E., Jichlinski P., Meuwly J.Y., Mirimanoff R.O., Ozsahin M. et al., 2011. Cancer Radiothérapie, 15 (4) pp. 307-315.
[DOI][WoS][Pmid][serval:BIB_4D5186A00AD2]
 
Intérêt des marqueurs sanguins dans la prédiction de la toxicité radio-induite [Interest of blood markers in predicting radiation-induced toxicity].
Lacombe J., Solassol J., Coelho M., Ozsahin M., Azria D., 2011. Cancer Radiothérapie, 15 (5) pp. 390-393.
[DOI][WoS][Pmid][serval:BIB_440096CFA594]
 
Low-dose radiotherapy in indolent lymphoma.
Rossier C., Schick U., Miralbell R., Mirimanoff R.O., Weber D.C., Ozsahin M., 2011. International Journal of Radiation Oncology, Biology, Physics, 81 (3) pp. e1-e6.
[DOI][WoS][Pmid][serval:BIB_F14CA043B977]
 
Mandibular osteoradionecrosis in squamous cell carcinoma of the oral cavity and oropharynx: incidence and risk factors.
Monnier Y., Broome M., Betz M., Bouferrache K., Ozsahin M., Jaques B., 2011. Otolaryngology head and Neck Surgery, 144 (5) pp. 726-32.
[DOI][WoS][Pmid][serval:BIB_39ACE12FBB5F]
 
Outcome and Prognostic Factors in Adenosquamous Carcinoma of the Head and Neck - a Multicenter Rare Cancer Network Study
Schick U., Betz M., Ghadjar P., Kaanders J.H.A.M., Demiroz C., Ozsahin M., 2011. pp. S555 dans European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, European Journal of Cancer. Peer-reviewed.
[WoS][serval:BIB_539C2EB80456]
 
Outcome and Prognostic Factors in Adenosquamous Carcinoma of the Head and Neck: A Multicenter Rare Cancer Network Study
Schick U., Betz M., Ghadjar P., Kaanders J.H.A.M., Ozsahin M., 2011. pp. S541-S542 dans ASTRO 2011, 53rd Annual Meeting of the American Society for Radiation Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.
[DOI][WoS][serval:BIB_9393D1BF0199]
 
Personalizing locoregional treatment in the adjuvant setting of early breast cancer on the basis of molecular background: an exciting enigma.
Tsoutsou P.G., Jeanneret Sozzi W., Matzinger O., Ozsahin M., 2011. Journal of Clinical Oncology, 29 (35) pp. 4721-2; author reply 4723-4. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_528D0EFF071B]
 
Primary testicular lymphoma: review
Boujelbene N., Ketterer N., Boujelbene N., Khanfir K., Bhagwati S., Herrmann E., Mirimanoff R. O., Ozsahin M., Zouhair A., 2011. Oncologie, 13 (9) pp. 598-604. Peer-reviewed.
[DOI][WoS][serval:BIB_3A98870D16D4]
 
Prise en charge des séminomes sécrétants de l'hormone chorionique gonadotrope [Management of chorionic gonadotropin-producing seminoma.]
Boujelbene N., Ozsahin M., Ugurluer G., Gaye M.P., Mirimanoff R.O., Zouhair A., 2011. Progrès en Urologie, 21 (5) pp. 308-313.
[DOI][WoS][Pmid][serval:BIB_7F2347D77CC1]
Pure seminoma: A review and update.
Boujelbene N., Cosinschi A., Boujelbene N., Khanfir K., Bhagwati S., Herrmann E., Mirimanoff R.O., Ozsahin M., Zouhair A., 2011. Radiation Oncology, 6 p. 90.
[URN][DOI][WoS][Pmid][serval:BIB_F4D093B682AF]
 
Quoi de neuf dans le traitement des séminomes  [What's new in the treatment of seminomas?]
Boujelbene N., Ozsahin M., Khanfir K., Azria D., Mirimanoff R.O., Zouhair A., 2011. Cancer Radiotherapie, 15 (3) pp. 208-220.
[DOI][WoS][Pmid][serval:BIB_94EE8B645D9C]
 
Secondary Cancer Risk for Stage 1 Seminoma Patients : a Comparaison of Adjuvant Treatments Versus Surveillance
Berthold D., Heym L., Le Coultre R., Joosten A., Verdun F., Moeckli R., Ozsahin M., Herrera F., 2011. dans ESMO 2011, European Society for Medical Oncology.
[serval:BIB_B35D45B17F5B]
 
Secondary Cancer Risk for Stage I Seminoma Patients - a Comparison of Adjuvant Treatment Versus Surveillance
Berthold D., Heym L., Le Coultre R., Joosten A., Verdun F., Moeckli R., Ozsahin M., Herrera F., 2011. pp. S511 dans European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, European Journal of Cancer. Peer-reviewed.
[WoS][serval:BIB_B5325D985752]
Sequential or concomitant chemotherapy in limited stage small-cell lung cancer.
Khanfir K., Elhfidh M., Anchisi S., Matzinger O., Bieri S., Mirimanoff R.O., Ozsahin M., Zouhair A., 2011. Swiss Medical Weekly, 141 pp. w13205.
[URN][DOI][WoS][Pmid][serval:BIB_965E5B4C2B4A]
Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study.
Onal C., Li Y.X., Miller R.C., Poortmans P., Constantinou N., Weber D.C., Atasoy B.M., Igdem S., Ozsahin M., Ozyar E., 2011. Annals of Oncology, 22 (1) pp. 156-164.
[URN][DOI][WoS][Pmid][serval:BIB_B64146B4B35F]
2010
 
Chimioradiothérapie postopératoire des cancers des voies aérodigestives : vers un nouveau standard ? [Post-operative radiochemotherapy of the head and neck: Towards new standards?]
Zouhair A., Matzinger O., Azria D., Gaye M.P., Ugurluer G., El Hfid M., Mirimanoff R.O., Ozsahin M., 2010/06. Cancer radiotherapie, 14 (3) pp. 217-221. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_620E1CAF29D7]
 
Concomitant Cisplatin and Hyperfractionated Radiotherapy in Locally Advanced Head and Neck Cancer: Ten-year Follow-up of a Randomized Phase III Trial (SAKK 10/94)
Ghadjar P., Simcock M., Studer G., Allal A.S., Ozsahin M., Bernier J., Toepfer M., Zimmermann F., Glanzmann C., Aebersold D.M., 2010. pp. S28 dans 52nd Annual Meeting of the American Society for Radiation Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.
[WoS][serval:BIB_E9405E983657]
 
Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial.
Azria David, Belkacemi Yazid, Romieu Gilles, Gourgou Sophie, Gutowski Marian, Zaman Khalil, Moscardo Carmen Llacer, Lemanski Claire, Coelho Michael, Rosenstein Barry et al., 2010. Lancet Oncology, 11 (3) pp. 258-265.
[DOI][WoS][Pmid][serval:BIB_F0D3E362858F]
 
Early Stage Primary Bone Lymphoma: A Retrospective, Multicenter Rare Cancer Network Study
Cai L., Stauder M.C., Zhang Y.J., Poortmans P., Li Y.X., Constantinou N., Thariat J., Kadish S., Ozsahin M., Mirimanoff R.O., 2010. pp. S84 dans 52nd Annual Meeting of the American-Society-For-Radiation-Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.
[WoS][serval:BIB_B7EDAF6A30D1]
 
Early-stage favorable Hodgkin's lymphoma: is chemotherapy alone sufficient?
Ozsahin Mahmut, Ozsahin Hulya, 2010. Journal of Clinical Oncology, 28 (32) pp. 668-669; author reply 670.
[DOI][WoS][Pmid][serval:BIB_D3EFF4F722BB]
 
Extraovarian primary peritoneal carcinoma
Nay Fellay C., Fiche M., Delaloye J.F., Bauer J., 2010. pp. 279-292 dans Belkacemi Yazid, Mirimanoff René-Olivier, Ozsahin Mahmut (eds.) Management of Rare Adult Tumours chap. 2, Springer.
[DOI][serval:BIB_FC1C78EA5408]
 
Facteurs de radiosensibilité tardive des tissus sains [Factors of late radiosensitivity of normal tissues]
Azria D., Pointreau Y., Toledano A., Ozsahin M., 2010. Cancer Radiothérapie, 14 (4-5) pp. 250-254.
[DOI][WoS][Pmid][serval:BIB_1E09C4F55A72]
 
Mandibular Osteoradionecrosis in Squamous-Cell Carcinoma of the Oral Cavity and Oropharynx Incidence and Risk Factors
Betz M., Ozsahin M., Broome M., Bouferrache K., Jaques B., Monnier V., 2010. p. 721 dans 14th Annual Meeting of the Scientific-Association-of-Swiss-Radiation-Oncology (SASRO), Strahlentherapie und Onkologie. Peer-reviewed.
[WoS][serval:BIB_DA3DBBA5A0E1]
 
Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
Ozsahin Mahmut, Gruber Guenther, Olszyk Olimpia, Karakoyun-Celik Omur, Pehlivan Berrin, Azria David, Roelandts Martine, Kaanders Johannes H. A. M., Cengiz Mustafa, Krengli Marco et al., 2010. International Journal of Radiation Oncology, Biology, Physics, 78 (4) pp. 992-997.
[DOI][WoS][Pmid][serval:BIB_A3C81E57C6AA]
 
Positron Emission Tomography and Computer Tomography (PET/CT) in Prostate, Bladder, and Testicular Cancers.
Zouhair A., Ozsahin M., Schaffer M., Albrecht S., Camus F., Jichlinski P., Mirimanoff R.O., Delaloye A.B., Meuwly J.Y., Prior J.O., 2010. Current Medicinal Chemistry, 17 (23) pp. 2492-502.
[DOI][WoS][Pmid][serval:BIB_E1C19424CA0E]
Primary testicular lymphoma.
Zouhair A., Herrmann E., Ugurluer G., Gaye P.M., Mirimanoff R.O., Ozsahin M., 2010. Swiss Medical Weekly, 140 pp. w13076.
[DOI][Pmid][serval:BIB_662EFFE322A4]
 
Radiation therapy for the solitary plasmacytoma
Kocak Esenguel, Ballerini Giorgio, Zouhair Abderrahim, Ozsahin Mahmut, 2010. Turkish Journal of Hematology, 27 (2) pp. 57-61.
[DOI][WoS][serval:BIB_0EEF3E165E2C]
Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Subcommittee.
Psyrri A., Licitra L., Lacombe D., Schuuring E., Budach W., Ozsahin M., Knecht R., Vermorken J.B., Langendijk J.A., 2010. Annals of Oncology, 21 (10) pp. 1952-1960.
[URN][DOI][WoS][Pmid][serval:BIB_22BFE2C6FAC4]
2009
 
A phase 2 randomized trial of radiotherapy (RT) plus panitumumab compared to chemoradiotherapy in patients with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): interim pooled safety analysis
Giralt J., Trigo J.M., Nuyts S., Ozsahin M., Markowitz A.B., Daisne J., Skladowski K., Lonchay C., Holeckova P., Smitt M., 2009. p. 475 dans 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology, EJC Supplements. Peer-reviewed.
[DOI][WoS][serval:BIB_8A180C98D700]
 
Adenoid Cystic Carcinoma of the Breast: A Rare Cancer Network Study
Ozsahin E., Sozzi W. Jeanneret , Kallel A., Villette S., Belkacemi Y., Vautravers C., Nguyen T., Miller R., Li Y.X., Khanfir K., 2009. pp. 184-185 dans 51st Annual Meeting of the American-Society-for-Radiation-Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.
[DOI][WoS][serval:BIB_8CB0D3AF30E3]
 
Concurrent or Sequential Adjuvant Hormonoradiotherapy after Conservative Surgery for Early-Stage Breast Cancer: Clinical Results of the CO-HO-RT Phase II Randomized Trial.
Azria D., Ozsahin M., Romieu G., Gourgou S., Gutowski M., Zaman K., Lemanski C., Llacer C., Rosenstein B., Belkacemi Y., 2009. p. 536 dans 32nd Annual San Antonio Breast Cancer Symposium, Cancer Research. Peer-reviewed.
[WoS][serval:BIB_9EA8A32C182E]
Decrease in hemoglobin levels following surgery influences the outcome in head and neck cancer patients treated with accelerated postoperative radiotherapy.
Pehlivan B., Zouhair A., Luthi F., Bron L., Pasche P., Dragusanu D., Azria D., Matzinger O., Mirimanoff R.O., Ozsahin M., 2009. Annals of Surgical Oncology, 16 (5) pp. 1331-1336.
[URN][DOI][WoS][Pmid][serval:BIB_9F24F250B93C]
Feasibility and efficacy of accelerated weekly concomitant boost postoperative radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer.
Pehlivan B., Luthi F., Matzinger O., Betz M., Dragusanu D., Bulling S., Bron L., Pasche P., Seelentag W., Mirimanoff R.O. et al., 2009. Annals of Surgical Oncology, 16 (5) pp. 1337-1343.
[URN][DOI][WoS][Pmid][serval:BIB_CE90665A3DFA]
 
High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes.
Giro C., Berger B., Bölke E., Ciernik I.F., Duprez F., Locati L., Maillard S., Ozsahin M., Pfeffer R., Robertson A.G. et al., 2009. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 90 (2) pp. 166-71. Peer-reviewed.
[DOI][Pmid][serval:BIB_CC85108C4935]
 
Hormono-radiothérapie adjuvante des cancers du sein [Adjuvant breast cancer treatment with hormono-radiotherapy]
Azria D., Jacot W., Gligorov J., Belkacémi Y., Zaman K., Romieu G., Ozsahin M., 2009. Bulletin du Cancer, 96 (3) pp. 285-289.
[DOI][WoS][Pmid][serval:BIB_9B1E8E79A3E5]
 
Irradiation corporelle totale : présent et avenir [Total body irradiation: present and future]
Zilli T., Miralbell R., Ozsahin M., 2009. Cancer Radiothérapie, 13 (5) pp. 428-433.
[DOI][WoS][Pmid][serval:BIB_47B085C31ED5]
 
Low dose (2x2 Gy) radiotherapy in indolent lymphoma : 2661
Schick U., Rossier C., Weber D.C., Ketterer N., Miralbell R., Mirimanoff R.O., Ozsahin M., 2009. p. 479 dans 51st Annual Meeting of the American-Society-for-Radiation-Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.
[serval:BIB_368C952E4CB7]
Management of transitional-cell carcinoma of the renal pelvis and ureter.
Ozsahin M., Ugurluer G., Zounair A., 2009. Swiss Medical Weekly, 139 (25-26) pp. 353-356. Peer-reviewed.
[URN][WoS][Pmid][serval:BIB_B83DB9728685]
 
Physical considerations on discrepancies in target volume delineation.
Moeckli Raphael, Jeanneret Sozzi Wendy, Mirimanoff Rene-Olivier, Ozsahin Mahmut, Zouhair Abderrahim, Valley Jean-Francois, Bochud Francois, 2009. Zeitschrift für Medizinische Physik, 19 (4) pp. 224-235. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_768C4DD3E807]
 
Radiochemotherapy in locally advanced squamous cell carcinomas of the head and neck.
Matzinger O., Zouhair A., Mirimanoff R.O., Ozsahin M., 2009. Clinical Oncology, 21 (7) pp. 525-531.
[DOI][WoS][Pmid][serval:BIB_A882E991129E]
2008
 
Open low-field magnetic resonance imaging for target definition, dose calculations and set-up verification during three-dimensional CRT for glioblastoma multiforme.
Weber D.C., Wang H., Albrecht S., Ozsahin M., Tkachuk E., Rouzaud M., Nouet P., Dipasquale G., 2008/10. Clinical Oncology (Royal College of Radiologists (Great Britain)), 20 (2) pp. 157-167. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FB0B7CB085F1]
 
Traitements systémiques du cancer colorectal métastatique [Systemic treatment of metastatic colorectal cancer]
Montemurro M., Achtari L., Röth A., Halkic N., Luthi F., Ozsahin M., Denys A., Bauer J., Demartines N., Leyvraz S., 2008/05/21. Revue medicale suisse, 4 (158) pp. 1254-1257. Peer-reviewed.
[Pmid][serval:BIB_FCC1F9756723]
 
Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
Goldberg H., Miller R.C., Abdah-Bortnyak R., Steiner M., Yildiz F., Meirovitz A., Villà S., Poortmans P.M., Azria D., Zidan J. et al., 2008/02. Gynecologic oncology, 108 (2) pp. 298-305. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DDD6255445F4]
 
Cancers du sein : comment associer l'hormonothérapie et la radiothérapie en situation adjuvante [How to combine hormonotherapy and radiation treatment in adjuvant breast cancer?]
Azria D., Ozsahin M., Gligorov J., Zaman K., Llacer Moscardo C., Lemanski C., Jacot W., Belkacémi Y., 2008. Cancer Radiothérapie, 12 (1) pp. 37-41.
[DOI][WoS][Pmid][serval:BIB_50E09CB712B4]
 
Concurrent or sequential adjuvant hormonoradiotherapy after conservative surgery for early stage breast cancer : first results of the CO-HO-RT phase II randomized trial : poster 234
Azria D., Ozsahin M., Romieu G., Gourgou S., Lemanski C., Belkacemi Y., Zaman K., 2008. p. 117 dans EBCC-6, European Breast Cancer Conference, European Journal of Cancer. Supplement. Peer-reviewed.
[serval:BIB_AB70BA3CE1E6]
 
Concurrent or sequential adjuvant hormonoradiotherapy after conservative surgery for early stage breast cancer: First results of the CO-HO-RT phase II randomized trial
Azria D., Belkacemi Y., Romieu G., Gourgou-Bourgade S., Zaman K., Gutowski M., Rosenstein B.S., Llacer Moscardo C., Lemanski C., Ozsahin M., 2008. p. 556 dans 2008 ASCO Annual Meeting, Journal of Clinical Oncology. Peer-reviewed.
[serval:BIB_D4EC272A519A]
 
Pelvic radiotherapy and chemotherapy with or without surgery in the management of metastatic rectal cancer
Zouhair A., Ozsahin M., Ychou M., Dubois J.B., Mirimanoff R.O., Azria D., 2008. p. 15030 dans 2008 ASCO Annual Meeting, Journal of Clinical Oncology. Peer-reviewed.
[serval:BIB_4B316D4597E5]
 
Phyllodes tumor of the breast.
Belkacémi Y., Bousquet G., Marsiglia H., Ray-Coquard I., Magné N., Malard Y., Lacroix M., Gutierrez C., Senkus E., Christie D. et al., 2008. International Journal of Radiation Oncology, Biology, Physics, 70 (2) pp. 492-500. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_11319121633A]
 
Pilot study of induction chemotherapy followed by concomitant chemotherapy and IMRT or tomotherapy for nasopharyngeal carcinoma
Matzinger O., Ozsahin M., Bron L., Luthi F., 2008. dans 7th International Conference on Head and Neck Cancer.
[serval:BIB_1AB75A082218]
 
Postoperative combined radiotherapy (RT) and chemotherapy (CT) in patients with resected gastric adenocarcinoma
Khanfir K., Zouhair A., Bieri S., Montemurro M., Anchisi S., Zenhäusern R., Cornu P., Pachoud M., Mirimanoff RO., Ozsahin M., 2008. dans 12th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO).
[serval:BIB_7B4F09662C62]
 
Radiation-induced side effects with or without systemic therapies: Prime time for prediction of individual radiosensitivity
Azria David, Rosenstein Barry S., Ozsahin Mahmut, 2008. International Journal of Radiation Oncology Biology Physics, 71 (5) pp. 1293-1294.
[DOI][WoS][serval:BIB_D9A83DCB6A7C]
 
Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy.
Azria D., Ozsahin M., Kramar A., Peters S., Atencio D.P., Crompton N.E., Mornex F., Pèlegrin A., Dubois J.B., Mirimanoff R.O. et al., 2008. Clinical Cancer Research, 14 (19) pp. 6284-6288. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E894A2187610]
 
Séquelles radio-induites et tests prédictifs [Radiation-induced sequelae: toward an individual profile]
Azria D., Belkacemi Y., Lagrange J.L., Chapet O., Mornex F., Maingon P., Hennequin C., Rosenstein B., Ozsahin M., 2008. Cancer Radiothérapie, 12 (6-7) pp. 619-624. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F5B122E111A6]
2007
 
Multicenter phase II randomized trial evaluating toxicities of concurrent and sequential radiotherapy and letrozole (CO-HO-RT) as adjuvant therapy after conservative surgery in postmenopausal women with hormone receptor positive tumors: Preliminary results.
Azria D, Ozsahin M, Rosenstein B, Romieu G, Gutowski M, Zaman K, Llacer Moscardo C, Lemanski C, Jeanneret-Sozzi W, Gligorov J, Gourgou-Bourgade S, Larbouret C, Pèlegrin A, Dubois J.B., Belkacémi Y (eds.), 2007/12..
[serval:BIB_4140F38EC691]
 
Outcome and prognostic factors in breast sarcoma: A multicenter study from the rare cancer network
Bousquet G., Confavreux C., Magne N., de Lara C. T., Poortmans P., Senkus E., de Lafontan B., Bolla M., Largillier R., Lagneau E. et al., 2007/12. Radiotherapy and Oncology, 85 (3) pp. 355-61. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D9E31BDA6C06]
 
Conservative management in patients with carcinoma of the anal margin
Khanfir K., Ozsahin M., Bieri S., Moeckli R., Mirimanoff R.O., Zouhair A., 2007. pp. S298 dans 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.
[DOI][WoS][serval:BIB_76027DCE6D1B]
 
Improvement of saliva production in ENT cancer patients treated by IMRT
Bouferrache K., Moller R., Ozsahin E.M., Moeckli R., Madrid C., 2007. p. 56 dans Abstracts of the First World Congress of the International Academy of Oral Oncology (IAOO), Oral Oncology Supplement. Peer-reviewed.
[DOI][WoS][serval:BIB_5E3648B82A35]
 
Location, number and clinical significance of nutrient foramina in human long bones.
Kizilkanat E., Boyan N., Ozsahin E.T., Soames R., Oguz O., 2007. Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft, 189 (1) pp. 87-95. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C8CDE63EF1A8]
 
Postoperative 3D conformal radiation therapy with dose-volume histogram assessment in non small-cell lung cancer
Zouhair A., Drausanu D., Matzinger O., Pehlivan B., Khanfir K., Ris H.B., Stupp R., Moeckli R., Mirimanoff R.O., Ozsahin M., 2007. pp. S498-S499 dans 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.
[DOI][WoS][serval:BIB_C9A972CD5FE4]
 
Postoperative 3D conformal RT (PORT) in non small cell lung cancer (NSCLC)
Dragusonu D., Ozsahin M., Ris H. B., Khanfir K., Stupp R., Matzinger O., Moeckli R., Mirimanoff R.O., Zouhair A., 2007. p. 173 dans 11th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO), Strahlentherapie und Onkologie. Peer-reviewed.
[WoS][serval:BIB_600E08A9B93A]
 
Radiochimiothérapie dans les cancers ORL (EGFR+) [Radio-chemotherapy in head and neck cancer (EGFR+)].
Ozsahin M., Matzinger O., Zimmermann M., Zouhair A., 2007. Bulletin du Cancer, 94 (9) pp. 828-832.
[WoS][Pmid][serval:BIB_204AB02D8A2B]
2006
 
Facteurs pronostiques et prise en charge des tumeurs rares. [Prognostic factors and management of rare cancers]
Belkacemi Y., Zouhair A., Ozsahin M., Azria D., Mirimanoff R. O., 2006/11. Cancer RadioThérapie, 10 (6-7) pp. 323-9.
[DOI][Pmid][serval:BIB_95E447402BBB]
 
Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network study
Ozyar E., Selek U., Laskar S., Uzel O., Anacak Y., Ben-Arush M., Polychronopoulou S., Akman F., Wolden S. L., Sarihan S. et al., 2006/10. Radiotherapy and Oncology, 81 (1) pp. 39-46. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9E5EEFA888F0]
 
Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network
Weber D. C., Miller R. C., Villa S., Hanssens P., Baumert B. G., Castadot P., Varlet P., Abacioglu U., Igdem S., Szutowicz E. et al., 2006/09. International Journal of Radiation Oncology, Biology, Physics, 66 (1) pp. 179-86. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0648AC389011]
 
Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network
Omlin A., Amichetti M., Azria D., Cole B. F., Fourneret P., Poortmans P., Naehrig D., Miller R. C., Krengli M., Gutierrez Miguelez C. et al., 2006/08. Lancet Oncology, 7 (8) pp. 652-6. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2BFB3FDC59F8]
 
Genetic predictors of adverse radiotherapy effects: the Gene-PARE project
Ho A. Y., Atencio D. P., Peters S., Stock R. G., Formenti S. C., Cesaretti J. A., Green S., Haffty B., Drumea K., Leitzin L. et al., 2006/07. International Journal of Radiation Oncology, Biology, Physics, 65 (3) pp. 646-55. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F8E9BF0EFFA7]
 
Primary spinal epidural lymphoma: patients' profile, outcome, and prognostic factors: a multicenter Rare Cancer Network study
Monnard V., Sun A., Epelbaum R., Poortmans P., Miller R. C., Verschueren T., Scandolaro L., Villa S., Majno S. B., Ostermann S. et al., 2006/07. International Journal of Radiation Oncology, Biology, Physics, 65 (3) pp. 817-23. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_275F5C3153A0]
 
Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy.
Ozsahin M., Betz M., Matzinger O., Bron L., Luthi F., Pasche P., Azria D., Mirimanoff R.O., Zouhair A., 2006. Archives of Otolaryngology--Head and Neck Surgery, 132 (2) pp. 141-145. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_168851EBA7C3]
 
Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients
Ozsahin M., Tsang R. W., Poortmans P., Belkacemi Y., Bolla M., Dincbas F. O., Landmann C., Castelain B., Buijsen J., Curschmann J. et al., 2006/01. International Journal of Radiation Oncology, Biology, Physics, 64 (1) pp. 210-7.
[DOI][WoS][Pmid][serval:BIB_3A10AEB3C6E9]
Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study.
Knobel D., Zouhair A., Tsang R.W., Poortmans P., Belkacémi Y., Bolla M., Oner F.D., Landmann C., Castelain B., Ozsahin M., 2006. BMC Cancer, 6 p. 118. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2D5473DF94BF]
 
The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications.
Zimmermann M., Zouhair A., Azria D., Ozsahin M., 2006. Radiation Oncology, 1 p. 11.
[DOI][WoS][Pmid][serval:BIB_510E90C30673]
The reasons for discrepancies in target volume delineation : a SASRO study on head-and-neck and prostate cancers.
Jeanneret-Sozzi W., Moeckli R., Valley J.F., Zouhair A., Ozsahin E.M., Mirimanoff R.O., 2006. Strahlentherapie und Onkologie, 182 (8) pp. 450-457. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0DD4945B41E1]
 
Treatment of penile carcinoma: to cut or not to cut?
Ozsahin M., Jichlinski P., Weber D.C., Azria D., Zimmermann M., Guillou L., Bulling S., Moeckli R., Mirimanoff R.O., Zouhair A., 2006. International Journal of Radiation Oncology, Biology, Physics, 66 (3) pp. 674-679. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8FB576FEC915]
2005
 
Protective role of melatonin in pinealectomized rat brains: in vivo magnetic resonance spectroscopic analysis
Hascalik S., Celik O., Karakas H. M., Parlakpinar H., Firat A. K., Ozsahin M., 2005/11. Journal of Pineal Research, 39 (4) pp. 342-5. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FBDB58782C21]
 
Radiation recall: a well recognized but neglected phenomenon
Azria D., Magne N., Zouhair A., Castadot P., Culine S., Ychou M., Stupp R., Van Houtte P., Dubois J. B., Ozsahin M., 2005/11. Cancer Treatment Reviews, 31 (7) pp. 555-70.
[DOI][WoS][Pmid][serval:BIB_7379F66B3A9E]
 
Stature estimation based on hand length and foot length
Sanli S. G., Kizilkanat E. D., Boyan N., Ozsahin E. T., Bozkir M. G., Soames R., Erol H., Oguz O., 2005/11. Clinical Anatomy, 18 (8) pp. 589-96.
[DOI][WoS][Pmid][serval:BIB_7FBC4A27D14E]
 
CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients
Ozsahin M., Crompton N. E., Gourgou S., Kramar A., Li L., Shi Y., Sozzi W. J., Zouhair A., Mirimanoff R. O., Azria D., 2005/10. Clinical Cancer Research, 11 (20) pp. 7426-33.
[DOI][WoS][Pmid][serval:BIB_716962901C2A]
 
Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
Bernier J., Cooper J. S., Pajak T. F., van Glabbeke M., Bourhis J., Forastiere A., Ozsahin E. M., Jacobs J. R., Jassem J., Ang K. K. et al., 2005/10. Head and Neck, 27 (10) pp. 843-50.
[DOI][WoS][Pmid][serval:BIB_5A071662DC7D]
 
Radiation therapy and tamoxifen: concurrent or sequential? It's no longer the question!
Azria D., Pelegrin A., Dubois J.B., Mirimanoff R.O., Ozsahin M., 2005/06. Journal of Clinical Oncology, 23 (18) pp. 4239-4241; author reply 4241-4242. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E9922DB10A1E]
 
Anémie et cancers des voies aérodigestives supérieures [Anemia in head and neck cancers]
Azria D., Zouhair A., Serre A., Lemanski C., Schneider M., Ozsahin M., Dubois J.B., Lartigau E., 2005/05. Bulletin du Cancer, 92 (5) pp. 445-451.
[WoS][Pmid][serval:BIB_64D201CBE58B]
External radiotherapy and anaemia treatment: state of the art.
Ozsahin M., Azria D., Beer K., Mirimanoff R.O., Zouhair A., 2005/01/08. Swiss medical weekly, 135 (1-2) pp. 4-10. Peer-reviewed.
[URN][WoS][Pmid][serval:BIB_8BEEB0A26553]
Combined modality treatment with full-dose chemotherapy and concomitant boost radiotherapy for advanced head and neck carcinoma
Kutter J., Ozsahin M., Monnier P., Stupp R., 2005/01. European Archives of Oto-Rhino-Laryngology, 262 (1) pp. 1-7.
[URN][DOI][WoS][Pmid][serval:BIB_F1B109E7527F]
 
Do sensitive patients have sensitive tumors?
Ozsahin M., Zouhair A., Crompton N.E.A., Moeckli R., Li L., Mirimanoff R.O., Azria D., 2005. pp. 504S dans 2005 ASCO Annual Meeting of the American Society of Clinical Oncology, Journal of Clinical Oncology. Peer-reviewed.
[WoS][serval:BIB_5A6A2B5DF908]
 
Letrozole sensitizes breast cancer cells to ionizing radiation
Azria D., Larbouret C., Cunat S., Ozsahin M., Gourgou S., Martineau P., Evans D. B., Romieu G., Pujol P., Pelegrin A., 2005. Breast Cancer Research, 7 (1) pp. R156-63. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A4CAE8B80263]
Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.
Azria D., Bibeau F., Barbier N., Zouhair A., Lemanski C., Rouanet P., Ychou M., Senesse P., Ozsahin M., Pèlegrin A. et al., 2005. BMC Cancer, 5 p. 62. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F3CE985028E6]
 
Radiation-induced CD8 T-lymphocyte apoptosis predicts tumor sensitivity in head and neck cancer
Ozsahin M., Zouhair A., Crompton N.E.A., Moeckli R., Li L., Gourgou S., Mirimanoff R.O., Azria D., 2005. pp. 402-403 dans ECCO 13, 13rd European Conference on Clinical Oncology and Cancer Nursing, European Journal of Cancer. Supplement. Peer-reviewed.
[WoS][serval:BIB_587D75EF9FD0]
 
Skin dose in conventional conformal and intensity modulated head and neck radiation therapy
Bulling S., Bresson S., Do H.P., Pache G., Ozsahin M., Mirimanoff R.O., Valley J.F., Moeckli R., 2005. p. 137 dans 9th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO), Strahlentherapie und Onkologie. Peer-reviewed.
[WoS][serval:BIB_BB5206A89579]
2004
 
Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients
Azria D., Gourgou S., Sozzi W. J., Zouhair A., Mirimanoff R. O., Kramar A., Lemanski C., Dubois J. B., Romieu G., Pelegrin A. et al., 2004/10. British Journal of Cancer, 91 (7) pp. 1251-60.
[DOI][WoS][Pmid][serval:BIB_78A35C7DC774]
 
La prévention des ossifications hétérotopiques après prothèse totale de la hanche. Mise au point [Prevention of heterotopic ossification following prosthetic total hip replacement]
Zouhair A., Ozsahin M., Garofalo R., Leyvraz P.F., Theumann N., Mirimanoff R.O., Coucke P.A., Mouhsine E., 2004/09. Revue medicale de la Suisse romande, 124 (9) pp. 579-582. Peer-reviewed.
[Pmid][serval:BIB_EF17DF310C1A]
 
Hormonoradiotherapie adjuvante concomitante des cancers du sein: etat de l'art. [Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art]
Azria D., Lemanski C., Zouhair A., Gutowski M., Belkacemi Y., Dubois J. B., Romieu G., Ozsahin M., 2004/06. Cancer RadioThérapie, 8 (3) pp. 188-96.
[DOI][Pmid][serval:BIB_81E4BA634F5F]
 
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer
Bernier J., Domenge C., Ozsahin M., Matuszewska K., Lefebvre J. L., Greiner R. H., Giralt J., Maingon P., Rolland F., Bolla M. et al., 2004/05. New England Journal of Medicine, 350 (19) pp. 1945-52. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7D5E10EB0204]
 
Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment
Miralbell R., Sancho G., Bieri S., Carrio I., Helg C., Brunet S., Martin P. Y., Sureda A., Gomez De Segura G., Chapuis B. et al., 2004/03. International Journal of Radiation Oncology, Biology, Physics, 58 (3) pp. 809-16. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ECA2B3897A0A]
 
A prospective study of salivary gland function in patients undergoing radiotherapy for squamous cell carcinoma of the oropharynx
Moller P., Perrier M., Ozsahin M., Monnier P., 2004/02. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics, 97 (2) pp. 173-89. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_20D3450030B2]
 
Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer
Zouhair A., Azria D., Pasche P., Stupp R., Chevalier J., Betz M., Mirimanoff R. O., Ozsahin M., 2004/02. Radiotherapy and Oncology, 70 (2) pp. 183-8.
[DOI][WoS][Pmid][serval:BIB_7EE7B9C7AC71]
 
Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.
Huguenin P., Beer K.T., Allal A., Rufibach K., Friedli C., Davis J.B., Pestalozzi B., Schmid S., Thöni A., Ozsahin M. et al., 2004. Journal of Clinical Oncology, 22 (23) pp. 4665-4673. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_77349890A2A0]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University